Top 5 VC Deals | AI

Top 5 VC Deals of the Week in AI (4/26/24)

By Cindy Taylor · Apr 26, 2024 Views: 6

Top 5 VC Deals of the Week in AI (4/26/24)
Our Top 5 VC Deals of the Week in AI featured fundings from Xaira Therapeutics, Augment, Cognition, Perplexity AI and Vetta Venture Partners


This week we continue our series on the top 5 VC-funded deals in AI.

This week's winners included the pharma sector with a WHOPPING $1 Billion USD raise, two AI coding assistance ventures, an AI-based search engine (watch out Google!), and an early stage AI-investing VC firm.

Below are the top 5 venture-funded AI deals for the past week that highlight the dynamic and rapidly evolving landscape of artificial intelligence, with the help of some research via ChatGPT (Though - ONCE AGAIN - it didn't make my job very easy this week!).


  1. Xaira Therapeutics - Xaira uses AI models to find new drugs
    • Funding Amount: $1B
    • Funding Round: Launch - out of stealth
    • Investors: Arch Venture Partners,  Foresite Capital (joint incubators of company,  Sequoia Capital and Lightspeed Venture Partners
  2. Augment - Offers AI coding assistance
    • Funding Amount: $227M
    • Funding Round: Series B
    • Investors: Sutter Hill Ventures, Index Ventures and Lightspeed Venture Partners
  3.  Cognition - Offers artificial intelligence–powered coding assistant named Devin
    • Funding Amount: $175M
    • Funding Round: Follow up to last month's Series A
    • Investors: Founders Fund
  4. Perplexity AI - AI search engine startup
    • Funding Amount: $63M
    • Funding Round: Follow up to January Series B
    • Investors: Daniel Gross, Nvidia, IVP, NEA, Jeff Bezos and Garry Tan
5. Vetta Venture Partners - An early-stage venture capital firm exclusively investing in AI-first startups

    • Funding Amount: $18 million
    • Funding Round: Series A funding
    • Investors: Not available
Make sure to check back weekly here for our "Top 5 VC AI Deals of the Week in AI"!


Article wirtten by DWN Staff with (minimal!) help from CoPilot Research Sources: Startupsavant, Crunchbase, Forbes, Globalventuring, Growthlist
Loading suggested stories…